{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:49:22Z","timestamp":1760150962642,"version":"build-2065373602"},"reference-count":4,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>An educational session related to the Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) was held virtually on 14 October 2020. The WCGCCC is an interactive multidisciplinary conference attended by health care professionals from across Western Canada (British Columbia, Alberta, Saskatchewan, and Manitoba), who are involved in the care of patients with gastrointestinal cancer. Surgical, medical, and radiation oncologists; pathologists, radiologists, and allied health care professionals participated in presentation and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses current issues in the management of total neoadjuvant therapy in rectal cancer.<\/jats:p>","DOI":"10.3390\/curroncol29020078","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T01:03:40Z","timestamp":1644368620000},"page":"924-927","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Report from the Western Canadian Gastrointestinal Consensus Cancer Conference\u2014Management of Total Neoadjuvant Therapy in Rectal Cancer"],"prefix":"10.3390","volume":"29","author":[{"given":"Howard","family":"Lim","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aswin George","family":"Abraham","sequence":"additional","affiliation":[{"name":"Cross Cancer Institute, Alberta Health Services, Edmonton, AB T6G 1Z2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2099-698X","authenticated-orcid":false,"given":"Shahid","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Saskatoon Cancer Center, Saskatchewan Cancer Agency, Saskatoon, SK S7N 4H4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahida","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl J.","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of British Columbia, Vancouver, BC V6T 1Z4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Brunet","sequence":"additional","affiliation":[{"name":"Saskatoon Cancer Center, Saskatchewan Cancer Agency, Saskatoon, SK S7N 4H4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Davies","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Doll","sequence":"additional","affiliation":[{"name":"Tom Baker Cancer Center, Alberta Health Service, Calgary, AB T2N 4H2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorie-Anna","family":"Dueck","sequence":"additional","affiliation":[{"name":"Saskatoon Cancer Center, Saskatchewan Cancer Agency, Saskatoon, SK S7N 4H4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vallerie","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Hagel","sequence":"additional","affiliation":[{"name":"Department of Oncology, Allan Blair Cancer Centre, Regina, SK S4T 7T1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Hebbard","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3847-2583","authenticated-orcid":false,"given":"Christina A.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duc","family":"Le","sequence":"additional","affiliation":[{"name":"Saskatoon Cancer Center, Saskatchewan Cancer Agency, Saskatoon, SK S7N 4H4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Lee-Ying","sequence":"additional","affiliation":[{"name":"Tom Baker Cancer Center, Alberta Health Service, Calgary, AB T2N 4H2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Paul","family":"McGhie","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, British Columbia Cancer Agency, Victoria, BC V8R 6V5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Mulder","sequence":"additional","affiliation":[{"name":"Cross Cancer Institute, Alberta Health Services, Edmonton, AB T6G 1Z2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of British Columbia, Vancouver, BC V6T 1Z4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Renouf","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devin","family":"Schellenberg","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, British Columbia Cancer Agency, Surrey, BC V3V 1Z2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph P. W.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Zaidi","sequence":"additional","affiliation":[{"name":"Saskatoon Cancer Center, Saskatchewan Cancer Agency, Saskatoon, SK S7N 4H4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): A randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1200\/JCO.2021.39.15_suppl.3509","article-title":"Survival and organ preservation according to clinical response after total neoadjuvant therapy in locally advanced rectal cancer patients: A secondary analysis from the organ preservation in rectal adenocarcinoma (OPRA) trial","volume":"39","author":"Thompson","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): A multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(17)31056-5","article-title":"Organ preservation for rectal cancer (GRECCAR 2): A prospective, randomised, open-label, multicentre, phase 3 trial","volume":"390","author":"Rullier","year":"2017","journal-title":"Lancet"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/2\/78\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:16:17Z","timestamp":1760134577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/2\/78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":4,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["curroncol29020078"],"URL":"https:\/\/doi.org\/10.3390\/curroncol29020078","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2022,2,8]]}}}